Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
18.01
-0.58 (-3.12%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Zenas BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1,071 | 1,949 | 342 | - | - |
| Market Cap Growth | 278.03% | 469.46% | - | - | - |
| Enterprise Value | 729 | 1,659 | -44 | - | - |
| Last Close Price | 18.01 | 36.31 | 8.19 | - | - |
| PS Ratio | 107.13 | 194.91 | 68.45 | - | - |
| PB Ratio | 4.05 | 8.05 | 1.10 | - | - |
| P/TBV Ratio | 4.42 | 8.05 | 1.10 | - | - |
| EV/Sales Ratio | 72.95 | 165.90 | - | - | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.87 | 0.03 |
| Net Debt / Equity Ratio | -1.41 | -1.41 | -1.12 | -1.47 | -1.37 |
| Net Debt / EBITDA Ratio | 1.62 | 1.62 | 2.14 | 1.32 | 0.87 |
| Net Debt / FCF Ratio | 1.98 | 1.98 | 2.92 | 1.17 | 1.00 |
| Asset Turnover | 0.03 | 0.03 | 0.02 | 0.70 | - |
| Quick Ratio | 5.50 | 5.50 | 6.16 | 2.44 | 2.59 |
| Current Ratio | 5.61 | 5.61 | 6.21 | 2.57 | 2.64 |
| Return on Equity (ROE) | -136.22% | -136.22% | -93.22% | -102.89% | - |
| Return on Assets (ROA) | -35.06% | -35.06% | -46.76% | -23.77% | - |
| Return on Capital Employed (ROCE) | -65.90% | -65.90% | -52.40% | -60.40% | -154.70% |
| Earnings Yield | -35.26% | -19.38% | -45.87% | - | - |
| FCF Yield | -16.09% | -8.84% | -35.00% | - | - |
| Buyback Yield / Dilution | -238.89% | -238.89% | -762.01% | -2.61% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.